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somatic cell counts, among others), have been associated with the occurrence of false 48 positive results (Andrew, 2001; Althaus et al., 2003) . Also, the presence of contaminants in 49 milk related to regular farming practices (detergents, disinfectants or antiparasitic 50 substances) may interfere with the microbial test responses (Romero et al., 2014; 2015) . 51 However, available information about this aspect is rather limited.
52
Antiparastic treatments are often applied to prevent and control various parasitic diseases.
53
Sarcoptic mange, caused by the ectoparasite Sarcoptes scabiei var. caprae, is a common 54 parasitic disease in caprine livestock causing considerable economic losses as milk 55 production is decreased (Wallton & Currie, 2007) . Additionally, it can have repercussions on 56 public health because of its potential transmission; therefore the antiparasitic treatment of 57 goats infested with sarcoptic mange becomes necessary.
58
Ivermectin (IVM) is one of the most effective drugs against scabies and other parasitic 59 diseases (McKellar & Benchaoui, 1996) . However, its use is not authorised in animals from 60 which milk is produced for human consumption (Commission Regulation (EU) No 37/2010) 61 due to the high persistence of IVM residues in milk (Alvinerie et al., 1993; Fernanda et al., 62 2004). Accordingly, the MRL for this substance in milk has not been established and, 63 4 therefore, the health impact of the illegal use of this drug in lactating dairy goats in unknown.
64
The European Medicine Agency (EMA, 2014) indicates that the Codex Alimentarius 65 establishes an MRL for IVM residues in milk at a concentration of 10 µg/kg, although more 66 studies about its potential effects are necessary to set the MRL in the European legislation.
67
The aim of this study was to evaluate the response of microbial inhibitor tests in milk from 68 dairy goats treated with IVM during lactation. The animals were milked in a milking parlour (08:00 a.m.) and the sampling was carried out 81 for 15 days after the first administration. Milk samples were analysed by microbial screening 82 tests and aliquots were frozen (-80 °C) for ivermectin quantification by HPLC. to an elevated concentration of IVM residues in milk, suggesting that factors associated to 134 drug administration other than residues in milk could be the cause of the interferences found. 135 Thus, for example, IVM has been evaluated as immunomodulatory showing a favourable 136 potential use as positive modulator (Stankiewwicz et al., 1995; Sajid et al., 2007) 
147
It can be concluded that the illegal application of IVM in lactating dairy goats infested with 148 sarcoptes mange produces persistent drug residues in milk and could also cause false-positive 149 results in microbial inhibitor tests for screening antibiotics. 
